.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05C_IrrigatingSolutions.B05CB10_ElectrolytesInCombinatio.ElectrolytesInCombinatio

Information

This preparation contains combinations of electrolytes such as sodium, potassium, calcium, and magnesium, typically used for intravenous infusion to correct or prevent disturbances in electrolyte and fluid balance, especially in clinical situations such as dehydration, surgery, or intensive care. ATC code B05CB10 specifically refers to solutions containing combinations of electrolytes. These combinations are still widely used and are considered standard supportive therapy in modern medicine.

Pharmacokinetics

No pharmacokinetic parameters specific to electrolyte solutions (combinations) for B05CB10 could be found in the literature, as electrolytes do not follow traditional pharmacokinetic models used for most drugs. Electrolyte kinetics depend on physiological and pathophysiological processes rather than standard compartmental PK models.

References

1. Bateman, RM, et al., & Prandi, E (2016). 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. Critical care (London, England) 20(Suppl 2) 94–None. DOI:10.1186/s13054-016-1208-6 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27885969

2. Levitskaia, TG, et al., & Thrall, KD (2010). Biomaterials for the decorporation of (85)Sr in the rat. Health physics 99(3) 394–400. DOI:10.1097/HP.0b013e3181c4717d PUBMED:https://pubmed.ncbi.nlm.nih.gov/20699703

3. Yang, S, et al., & Peachey, G (2021). Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN). Clinical pharmacokinetics 60(7) 887–896. DOI:10.1007/s40262-021-00988-1 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33598874

Revisions

• 06/2025 initial generated model